Merrimack Pharmaceuticals

Elevation files for $100M IPO to fund tumor-agnostic candidate
Fierce Biotech
Mon, 06/7/21 - 11:11 am
Elevation Oncology
IPOs
Merrimack Pharmaceuticals
solid tumors
Merrimack CEO, CFO bow out, months after last clinical drug fizzles
Endpoints
Wed, 07/3/19 - 10:07 am
Merrimack Pharmaceuticals
MM-310
Merrimack to Lay Off Remaining Execs and Staff, Sell Assets
BioSpace
Fri, 05/31/19 - 11:43 am
Merrimack Pharmaceuticals
layoffs
Merrimack zero for 3 as it dumps cancer drug over safety fears, axes staffers (again)
Fierce Biotech
Fri, 04/5/19 - 10:27 am
Merrimack Pharmaceuticals
adverse events
layoffs
MM-310
Merrimack cuts 60% of jobs, narrows R&D focus
Biopharma Dive
Wed, 11/7/18 - 10:36 pm
Merrimack Pharmaceuticals
layoffs
R&D
MM-121
Merrimack Pharma’s stock plunges (again) on its latest cancer drug trial flop
Endpoints
Fri, 10/19/18 - 09:40 am
Merrimack Pharmaceuticals
MM-121
non-small cell lung cancer
Pancreatic cancer study failure cripples a Merrimack drug, forcing a coup de grâce and pipeline retreat
Endpoints
Mon, 06/25/18 - 09:24 am
pancreatic cancer
MM-141
Merrimack Pharmaceuticals
These 3 Biotechs Have Been Crushed
Motley Fool
Wed, 06/21/17 - 11:45 pm
Xbiotech
Merrimack Pharmaceuticals
NewLink Genetics
Monday’s 4 Biggest Biopharma Movers
Yahoo/24-7 Wall St
Mon, 01/9/17 - 06:39 pm
Ariad Pharma
Arrowhead
Alcobra
Merrimack Pharmaceuticals
France's Ipsen to buy Merrimack's pancreatic cancer drug, assets in $1 bln deal
Yahoo/Reuters
Mon, 01/9/17 - 09:54 am
Ipsen
France
Merrimack Pharmaceuticals
pancreatic cancer
Onivyde
​Sales of Merrimack’s new pancreatic cancer drug top $11M in Q1
Bizjournals.com
Tue, 05/3/16 - 10:09 am
Merrimack Pharmaceuticals
Onivyde
pancreatic cancer
3 Scorned Biotechs Destined to Rebound
TheStreet.com
Wed, 01/20/16 - 10:25 am
Merrimack Pharmaceuticals
Relypsa
Amgen
AbbVie
Dynavax
FDA clears Merrimack's pancreatic cancer drug with warning
Yahoo/Reuters
Thu, 10/22/15 - 07:28 pm
FDA
Merrimack Pharmaceuticals
pancreatic cancer
warnings
Onivyde
​With pending drug approval, Merrimack Pharma set to be area's next commercial biotech
Bizjournals.com
Tue, 09/8/15 - 02:02 pm
Merrimack Pharmaceuticals
MM-398
FDA
U.S. FDA Grants Priority Review for MM-398 New Drug Application
Yahoo
Thu, 06/25/15 - 08:59 am
FDA
MM-398
Merrimack Pharmaceuticals
metastatic pancreatic cancer
Merrimack Pharmaceuticals and Baxter BioScience Announce Completion of New Drug Application Submission to U.S. FDA for MM-398 as a Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer
Yahoo
Mon, 04/27/15 - 09:44 am
Merrimack Pharmaceuticals
Baxter International
MM-398
metastatic pancreatic cancer
Merrimack pancreatic cancer product candidate fast tracked
Seeking Alpha
Thu, 11/20/14 - 09:04 am
pancreatic cancer
Merrimack Pharmaceuticals
FDA
fast track
Merrimack Does Well to License Marginal Cancer Drug to Baxter
TheStreet.com
Wed, 09/24/14 - 08:30 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Baxter International
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals
Yahoo/Benzinga
Thu, 07/3/14 - 12:07 pm
FDA
drug approvals
Acadia
Alexion
InterMune
Merrimack Pharmaceuticals
Soliris
pimavanserin
MM-398
Esbriet
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Wed, 07/2/14 - 11:49 am
Alexion
InterMune
FDA
Acadia
Kythera
Intercept Pharmaceuticals
Merrimack Pharmaceuticals
Relypsa
MM-398
patiromer
Esbriet
ATX-101
Soliris
Flint
pimavanserin

Pages